| Literature DB >> 36016184 |
Sergio González-Acosta1,2, Victoria Baca-González1, Patricia Asensio-Calavia1,2, Andrea Otazo-Pérez1,2, Manuel R López1, Antonio Morales-delaNuez1, José Manuel Pérez de la Lastra1.
Abstract
Microbial resistance is a global health problem that will increase over time. Advances in insect antimicrobial peptides (AMPs) offer a powerful new approach to combat antimicrobial resistance. Invertebrates represent a rich group of animals for the discovery of new antimicrobial agents due to their high diversity and the presence of adaptive immunity or "immune priming". Here, we report a priming approach for Tenebrio molitor that simulates natural infection via the oral route. This oral administration has the advantage of minimizing the stress caused by conventional priming techniques and could be a viable method for mealworm immunity studies. When using inactivated microorganisms for oral priming, our results showed an increased survival of T. molitor larvae after exposure to various pathogens. This finding was consistent with the induction of antimicrobial activity in the hemolymph of primed larvae. Interestingly, the hemolymph of larvae orally primed with Escherichia coli showed constitutive activity against Staphylococcus aureus and heterologous activity for other Gram-negative bacteria, such as Salmonella enterica. The priming of T. molitor is generally performed via injection of the microorganism. To our knowledge, this is the first report describing the oral administration of heat-inactivated microorganisms for priming mealworms. This technique has the advantage of reducing the stress that occurs with the conventional methods for priming vertebrates.Entities:
Keywords: antimicrobial peptides; immune priming; in vitro antimicrobial assay; invertebrate immunity; mealworms; survival rate
Year: 2022 PMID: 36016184 PMCID: PMC9415734 DOI: 10.3390/vaccines10081296
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
Groups of experimental larvae according to the substance used for the priming and challenge. N corresponds with the number of larvae in each group.
| Group | Name | Priming | Challenge |
|
|---|---|---|---|---|
| 1 | Control | PBS | PBS | 70 |
| 2 | PBS-EC | PBS |
| 68 |
| 3 | EC-EC |
|
| 66 |
| 4 | PBS-SA | PBS |
| 67 |
| 5 | SA-SA |
|
| 70 |
| 6 | PBS-CA | PBS |
| 70 |
| 7 | CA-CA |
|
| 70 |
| 8 | PBS-BC | PBS |
| 69 |
| 9 | BC-BC |
|
| 69 |
Statistical measurements (mean and median) for the groups of T. molitor larvae challenged with four microorganisms after the priming procedures. The effects of priming and challenge among the groups were measured by Cox regression and the p-values, respectively.
| Name | Mean (Hours) | Median (Hours) | Priming | Challenge |
|---|---|---|---|---|
| PBS-PBS | 45.2 ± 1.04 | - | - | - |
| PBS-EC | 25.0 ± 2.12 | 25.0 ± 2.06 | 0.004 | <0.001 |
| EC-EC | 33.8 ± 1.94 | 42.0 ± 2.96 | ||
| PBS-SA | 24.2 ± 2.25 | 20.0 ± 2.92 | <0.001 | <0.001 |
| SA-SA | 38.5 ± 1.69 | 43.0 ± 2.51 | ||
| PBS-CA | 35.1 ± 1.97 | 44.0 ± 0.68 | 0.518 | <0.001 |
| CA-CA | 32.9 ± 1.96 | 42.0 ± 3.54 | ||
| PBS-BC | 40.0 ± 1.64 | - | 0.086 | 0.016 |
| BC-BC | 43.4 ± 1.45 | - |
(PBS-PBS) Control group, (PBS-EC) larvae primed with PBS and challenge with E. coli, (EC-EC) larvae primed and challenge with E. coli, (PBS-SA) larvae primed with PBS and challenge with S. aureus, (SA-SA) larvae primed and challenge with S. aureus, (PBS-CA) larvae primed with PBS and challenge with C. albicans, (CA-CA) larvae primed and challenge with C. albicans, (PBS-BC) larvae primed with PBS and challenge with B. cinerea, and (BC-BC) larvae primed and challenge with B. cinerea.
Figure 1Survival rates (number of alive/total individuals) of T. molitor larvae challenged with four microorganisms after priming procedures. (PBS-PBS) Control group, (PBS-EC) larvae primed with PBS and challenged with E. coli, (EC-EC) larvae primed and challenged with E. coli, (PBS-SA) larvae primed with PBS and challenged with S. aureus, (SA-SA) larvae primed and challenged with S. aureus, (PBS-CA) larvae primed with PBS and challenged with C. albicans, (CA-CA) larvae primed and challenged with C. albicans, (PBS-BC) larvae primed with PBS and challenged with B. cinerea, and (BC-BC) larvae primed and challenged with B. cinerea.
In vitro antimicrobial activity of T. molitor hemolymphs against the different microorganisms.
| Sample |
|
|
|
|
|
|---|---|---|---|---|---|
| PBS-PBS | −/−/− | +/+/+ | −/−/− | −/−/− | −/−/− |
| PBS-EC | −/−/− | P/P/+ | −/−/− | −/−/− | −/−/− |
| EC-EC | P/+/P | +/+/+ | −/−/− | −/−/− | P/P/P |
| PBS-SA | −/−/− | P/P/P | −/−/− | −/−/− | P/P/P |
| SA-SA | −/−/− | P/P/P | −/−/− | −/−/− | P/P/P |
| PBS-CA | −/−/− | P/P/P | −/−/− | −/−/− | −/−/− |
| CA-CA | −/−/− | P/+/P | −/−/− | −/−/− | −/−/− |
| PBS-BC | −/−/− | +/+/+ | −/−/− | −/−/− | −/−/− |
| BC-BC | −/−/− | P/+/+ | −/−/− | −/−/− | −/−/− |
(−) Negative, (+) positive, and (P) partial inhibition. (PBS-PBS) Control group, (PBS-EC) larvae primed with PBS and challenge with E. coli, (EC-EC) larvae primed and challenge with E. coli, (PBS-SA) larvae primed with PBS and challenge with S. aureus, (SA-SA) larvae primed and challenge with S. aureus, (PBS-CA) larvae primed with PBS and challenge with C. albicans, (CA-CA) larvae primed and challenge with C. albicans, (PBS-BC) larvae primed with PBS and challenge with B. cinerea, and (BC-BC) larvae primed and challenge with B. cinerea.